[Retracted] Integrative Nomogram of Computed Tomography Radiomics, Clinical, and Tumor Immune Features for Analysis of Disease-Free Survival of NSCLC Patients with Surgery

Table 3

Univariate Cox analysis for multiple factors.

Factors	Univariate Cox
	HR (95% CI)	value
Sex	1.4 (0.71–2.7)	0.34
Age	1 (0.97–1)	0.69
Immunophenotyping	0.61 (0.4–0.94)	0.026
PD-L1	1.3 (0.99–1.8)	0.063
CD8	1.3 (0.86–1.9)	0.23
CD3	1.4 (0.94–1.9)	0.1
CD4	1 (0.71–1.5)	0.91
Histologic structure	0.99 (0.54–1.8)	0.96
N stage	1.9 (1.4–2.6)	0.00018
T stage	2.1 (1.4–3.1)	0.00057
Clinical stage	1.6 (1.3–1.9)	4e − 05
Microvascular invasion	2.8 (1.5–5.4)	0.0017
Perineural invasion	1.9 (0.67–5.4)	0.23
Segment resection residue	0.48 (0.066–3.5)	0.47
Perineural invasion	1.2 (0.58–2.4)	0.67
Bronchial invasion	1 (0.42–2.4)	0.97
Surgical method	1.1 (0.76–1.4)	0.76
Smoking quantity (cigarette)	1.1 (0.8–1.4)	0.65
Family history of cancer	0.41 (0.17–0.97)	0.043
Spicule sign	2.2 (0.99–4.8)	0.052
Lobulation sign	0.88 (0.27–2.9)	0.83
Spinous protuberant sign	1.2 (0.52–2.7)	0.69
Vascular-bronchial convergent sign	1.6 (0.78–3.3)	0.2
Pleural indentation sign	1.2 (0.62–2.3)	0.58
Pure ground-glass opacity	1.2e − 08 (0-inf)	1
Solid opacity	13 (1.8–96)	0.011
Part-solid ground-glass	0.14 (0.019–1)	0.054
Cavitation	1.8 (0.57–6)	0.31
Vacuole sign	0.76 (0.29–1.9)	0.56
Necrosis	3.9 (0.52–29)	0.18
Calcification	1.9 (0.76–5)	0.17